Clinical trial
Treatment of Resectable Malignant Brain Tumors
NCT00415467 · M.D. Anderson Cancer Center, Other · Terminated
Key facts
| NCT number | NCT00415467 |
|---|---|
| Title | Treatment of Resectable Malignant Brain Tumors |
| Official title | Phase IV GliaSite® Radiation Therapy System Registry Protocol for the Treatment of Resectable Malignant Brain Tumors |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Brain Tumor |
| Intervention type | Device |
| Interventions | GliaSite Radiation Therapy System |
| Enrollment | 13 |
| Start date | Jan 1, 2005 |
| Primary completion | Nov 1, 2007 |
| Completion | Jul 1, 2008 |
| First posted | Dec 25, 2006 |
| Last update posted | Aug 2, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: